Active ingredientCyamemazineCat. No. P-C260-001CAS 3546-03-0Family · Pharmaceutical analytical standards
Cyamemazine
A phenothiazine antipsychotic, introduced in France in 1972 and later in Portugal. It is used mainly for anxiety linked to schizophrenia and other psychiatric disorders, and for anxiety during benzodiazepine withdrawal. This family brings together the active ingredient, labelled standards, nitrosamines and other impurities.
Did you know?Although classed as a typical antipsychotic, it behaves more like an atypical one: it strongly blocks serotonin 5-HT2A and 5-HT2C receptors, and the 5-HT2C blockade is credited with its marked anti-anxiety effect.
Go to the active ingredient →Active ingredientCyamemazineCat. No. P-C260-001CAS 3546-03-0
Active ingredientCyamemazine MaleateCat. No. P-C260-002CAS 25332-99-4
Isotopically labelledCyamemazine-d6Cat. No. P-C260-003CAS 1216608-24-0
NitrosamineN-Nitroso N-Desmethyl CyamemazineCat. No. P-C260-004
ImpurityCyamemazine sulfoxideCat. No. P-C260-005CAS 13384-45-7
ImpurityN-Desmethyl Cyamemazine MaleateCat. No. P-C260-006CAS 1590417-47-2No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.